Cell Therapy
6 December 2023
Oxford Biomedica Acquires ABL Europe
4 December 2023
Lee Buckler, SVP Advanced Therapies,
29 November 2023
FDA investigates T cell malignancy
28 November 2023
David Sourdive joins us in
28 November 2023
In this interview David Sourdive
27 November 2023
Stefanos Theoharis, CBO, Kiji Therapeutics
21 November 2023
Lindsey Clarke, VP Commercial at
16 November 2023
This Q&A from Advanced Therapies